Skip to main content
Premium Trial:

Request an Annual Quote

Lower and Lower It Goes

Obstacles to cheaper and cheaper sequencing are falling by the wayside, writes Eilene Zimmerman at CNN Money. She notes that when James Watson had his genome sequenced by 454 in 2007, it cost about $1 million, but newer technologies are bringing that cost drastically down.

"The cost-per-bit of biologic information is coming down faster than Moore's Law," Steven Burrill, from the financial services firm Burrill & Company tells her.

Exome sequencing is already hitting the $500 mark, and Life Technologies' Jonathan Rothberg says, "In three months, we'll be able to do one entire human genome for $1,000." Zimmerman adds that other technologies like nanopore sequencing could further affect the price of sequencing.

Still, those sequences have to be interpreted. "We have information available today beyond our ability to absorb it," Burrill adds.

The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.